Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (191-200 of 315) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|May 29, 2010
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomasAndrei R Shustov, Theodore A Gooley, Brenda M Sandmaier, et al.
Experimental Hematology|October 11, 2003
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcomeWolfgang A Bethge, Barry E Storer, Michael B Maris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 2002
Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitizationRichard A Nash, Alessandra Takatu, Ziding Feng, et al.
Veterinary Immunology and Immunopathology|May 16, 2019
Development and characterization of a canine-specific anti-CD94 (KLRD-1) monoclonal antibodyScott S Graves, Boglarka Gyurkocza, Diane M Stone, et al.
British Journal of Haematology|July 22, 2015
Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host diseaseJennifer E Vaughn, Ted Gooley, Richard T Maziarz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemiaAlessandra Takatu, Richard A Nash, Jan M Zaucha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2013
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell doseMerav Bar, Brenda M Sandmaier, Yoshihiro Inamoto, et al.
Blood|September 13, 2003
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patientsWilliam J Hogan, Michael Maris, Barry Storer, et al.
Haematologica|February 16, 2015
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trialMarco Mielcarek, Terrence Furlong, Barry E Storer, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Pageof 32

Showing results (191-200 of 315) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|May 29, 2010
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomasAndrei R Shustov, Theodore A Gooley, Brenda M Sandmaier, et al.
Experimental Hematology|October 11, 2003
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcomeWolfgang A Bethge, Barry E Storer, Michael B Maris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 2002
Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitizationRichard A Nash, Alessandra Takatu, Ziding Feng, et al.
Veterinary Immunology and Immunopathology|May 16, 2019
Development and characterization of a canine-specific anti-CD94 (KLRD-1) monoclonal antibodyScott S Graves, Boglarka Gyurkocza, Diane M Stone, et al.
British Journal of Haematology|July 22, 2015
Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host diseaseJennifer E Vaughn, Ted Gooley, Richard T Maziarz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemiaAlessandra Takatu, Richard A Nash, Jan M Zaucha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2013
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell doseMerav Bar, Brenda M Sandmaier, Yoshihiro Inamoto, et al.
Blood|September 13, 2003
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patientsWilliam J Hogan, Michael Maris, Barry Storer, et al.
Haematologica|February 16, 2015
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trialMarco Mielcarek, Terrence Furlong, Barry E Storer, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Pageof 32